.

        IMA

Husky acquires Multishot injection/rotary technology from MGS

Husky acquires Multishot injection/rotary technology from MGS

Injection moulding machine maker Husky Technologies has announced the acquisition of secondary injection unit and rotary platen technologies, known as Multishot, from MGS Healthcare Manufacturing (MGS), a provider of healthcare manufacturing solutions. Terms were not disclosed.

The Multishot acquisition further strengthens Husky’s position as a leading provider of integrated multi-material solutions across key industries, including medical, packaging, and consumer electronics.

This acquisition enables the integration of precision secondary injection units and rotary platens with Husky’s Altanium mould controller technology.

The Canadian machine maker says that integrating these advanced multi-shot technologies enhances its ability to provide comprehensive, high-performance, turn-key solutions tailored to the production of multi-material and multi-colour applications.

The addition of these technologies enables Husky to expand its offering of fully integrated, multi-material solutions, improving manufacturing efficiency and performance. It also creates new opportunities for growth in the packaging, medical, personal, and homecare markets, enabling producers to benefit from a more complete range of innovative, high-performing solutions.

“This acquisition reinforces our commitment to innovation and excellence,” said Robert Domodossola, President of Systems and Tooling, Husky. “By bringing these complementary technologies into our portfolio, we are enhancing our ability to serve customers with integrated, high-performance solutions that drive efficiency and growth.”

“MGS is pleased to announce the divestiture of its Multishot product line to Husky. As a global leader in injection moulding technology and a key strategic supplier to MGS, Husky is the ideal organisation to take over and continue advancement of the Multishot product line,” said Shawn Krenke, Chief Technology Officer, MGS.

Krenke also said that with this divestiture, MGS will focus on providing contract development and manufacturing to its healthcare customers.

Subscribe to Get the Latest Updates from IMA  Please click here



©2025 Injection Moulding Asia. All rights reserved.